Alhena program (Aqilion)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameAlhena program (Aqilion)
Drug Alias NamePROTAC protein degrader program (Aqilion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAqilion AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAqilion AB
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A